Sonic Innovations Crushed
Sonic Innovations (SNCI) was the Nasdaq's biggest price loser Tuesday after lowering second-quarter earnings guidance because of changes in the German health care system.
The Salt Lake City hearing-aid manufacturer expects to earn 2 to 4 cents a share in the quarter on sales of $24 million to $25 million. Analysts surveyed by Thomson First Call had been expecting earnings of 7 cents a share on sales of $27.1 million for the quarter.
According to the company, the shortfall is attributable to the implementation of a 10-euro fee for specialist doctor visits in Germany this year, and a decrease in reimbursement for hearing aids. The actions will mean that first-quarter revenue from Germany will be the company's highest this year.
"The unfortunate timing of this change just as we are reaching the critical mass that helps us generate stronger profitability magnifies the short-term effect of this issue," the company said.Sonic Innovations' stock was recently down $3.37, or 37%, to $5.80.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV